1. Home
  2. GOGO vs YDES Comparison

GOGO vs YDES Comparison

Compare GOGO & YDES Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Gogo Inc.

GOGO

Gogo Inc.

N/A

Current Price

$2.83

Market Cap

461.2M

ML Signal

N/A

YDES

YD Bio Limited Ordinary Shares

HOLD

Current Price

$2.57

Market Cap

543.0M

Sector

N/A

ML Signal

HOLD

Company Overview

Basic Information
Metric
GOGO
YDES
Founded
1991
2013
Country
United States
Taiwan
Employees
N/A
N/A
Industry
Telecommunications Equipment
Sector
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
461.2M
543.0M
IPO Year
2011
2024

Fundamental Metrics

Financial Performance
Metric
GOGO
YDES
Price
$2.83
$2.57
Analyst Decision
Hold
Analyst Count
2
0
Target Price
$15.00
N/A
AVG Volume (30 Days)
1.6M
30.7K
Earning Date
05-07-2026
05-12-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
0.08
N/A
Revenue
$910,491,000.00
N/A
Revenue This Year
$3.68
N/A
Revenue Next Year
$3.60
N/A
P/E Ratio
$35.38
N/A
Revenue Growth
104.74
N/A
52 Week Low
$2.77
$1.70
52 Week High
$12.50
$25.00

Technical Indicators

Market Signals
Indicator
GOGO
YDES
Relative Strength Index (RSI) 32.14 48.58
Support Level N/A $2.14
Resistance Level $4.89 $2.93
Average True Range (ATR) 0.28 0.30
MACD -0.16 0.06
Stochastic Oscillator 4.30 41.43

Price Performance

Historical Comparison
GOGO
YDES

About GOGO Gogo Inc.

Gogo Inc is a broadband connectivity service for the business aviation market. It provides a customizable suite of smart cabin systems for integrated connectivity, inflight entertainment, and voice solutions. It generates two types of revenue: service revenue consists of monthly subscription and usage fees paid by aircraft owners and operators for telecommunication, data, and in-flight entertainment services, and equipment revenue consists of proceeds from the sale of ATG and narrowband satellite connectivity equipment and is recognized when control of the equipment is transferred to OEMs and dealers, which generally occurs when the equipment is shipped. Geographically, it operates in United States; and International as well.

About YDES YD Bio Limited Ordinary Shares

YD Bio Ltd is a biopharmaceutical company focusing on blood-based cancer detection, the development of stem cell- and exosome-based therapeutics with the potential to transform the treatment of a wide spectrum of diseases with high unmet medical need and serving as a trusted supplier of clinical testing drugs for pharmaceutical companies. Stem cell therapy uses versatile cells to repair or regenerate damaged tissues, offering innovative treatments for injuries, degenerative diseases, and immune disorders with potential for personalized medicine and tissue engineering.

Share on Social Networks: